info@cardiorenalsystems.com

+508-541-8800
Logo Logo Logo Logo Logo
  • Preventing Cardiac Surgery AKI
  • RenalPro Therapy
  • Publications
  • About Us
  • Manuals and Docs
  • USA Site
    • International
  • Preventing Cardiac Surgery AKI
  • RenalPro Therapy
  • Publications
  • About Us
  • Manuals and Docs
  • USA Site
    • International
Search:
w

02 Oct Driving growth: unleashing business agency”

Posted at 10:30h in Podcasts

...

Read More
w

02 Oct Introducing innovative ideas for corporate identity. 

Posted at 10:00h in Podcasts
Read More
w

02 Oct The single biggest reason why startups succeed. 

Posted at 09:41h in Podcasts
Read More
Categories
  • Podcasts
  • Trending
Recent posts
  • w
    Work tips: How to achieve more with your nine to five.
    26 September, 2023
  • w
    The single biggest reason why startups succeed. 
    02 October, 2023
  • w
    Latest news from the economy and digital world.
    24 September, 2023
Tags

Counseling Courses

w
Social media

© 2026 CardioRenal Systems Inc, All Rights Reserved

ED00120 Rev. A


The RenalGuard / RenalPro system and treatment have not been approved or cleared by the U.S. Food and Drug Administration (FDA). This device is currently available only for investigational use and is intended solely for use in clinical studies or other research settings under applicable regulatory guidelines.​ The system and treatment are CE approved for Fluid Balance Management. The system is branded as RenalGuard outside of the United States
CONTACT

CardioRenal Systems, Inc.
459 Fortune Boulevard
Milford, MA 01757
Tel: 508-541-8800
info@renalguard.com

Privacy Policy